Nyrada Inc - Annual Report 2021

Annual Report FY21 49 9. Issued capital 2021 2020 2021 2020 Shares Shares $ $ Ordinary shares - fully paid 156,008,700 109,383,722 25,320,332 15,607,349 Common Stock 30 June 2021 30 June 2020 30 June 2021 30 June 2020 Shares Shares $ $ At the beginning of reporting period/year 109,383,722 10,000 15,607,349 37,003 Adjustment as a result of stock splits - 29,784,970 - - Transfer from Option Reserve - - - 757,892 Issuance of Common Stock upon conversion of the Convertible Notes - 21,588,752 - 4,317,750 Issuance of Common Stock upon conversion of Noxopharm Loan - 13,500,000 - 2,700,000 Issue of Common Stock 44,231,154 44,500,000 11,500,899 8,700,000 Issue of Common Stock upon exercising of options 1,441,901 - 369,680 - Issuance of Common Stock - Advisors 951,923 - 304,615 - Share-based payments - exercise of options - - 183,152 - Less: Share placement costs - - (782,537) (905,296) Less: Share-based payments - Broker options - - (1,214,494) - Less: Share-based payments - reclassification in share capital - - (648,332) - At the end of reporting period/year 156,008,700 109,383,722 25,320,332 15,607,349 The Company has CHESS Depositary Interests (CDIs) quoted on the Australian Securities Exchange (ASX) trading under the ASX code NYR. Each CDI represents an interest in one share of Class A Common Stock of the Company (Share). Legal title to the Shares underlying the CDIs is held by CHESS Depositary Nominees Pty Ltd (CDN), a wholly owned subsidiary of the ASX. The Company’s securities are not quoted on any other exchange. CDI Holders are entitled to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. CDI Holders may attend and vote at Nyrada’s general meetings. The Company must allow CDI Holders to attend any meeting of Shareholders unless relevant U.S. law at the time of the meeting prevents CDI Holders from attending those meetings.